SLGL
Sol Gel Technologies Ltd
NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY
$74.04
+3.70% today
Updated 2026-04-30
Market cap
$230.14M
P/E ratio
—
P/S ratio
11.87x
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$4 – $98
Volume
0.0M
Sol Gel Technologies Ltd (SLGL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-31.60%
Operating margin
-497.90%
ROE
-23.70%
ROA
-14.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-4.85M | — | — | — |
| 2015 | $0.00 | $-9.66M | — | — | — |
| 2016 | $0.00 | $-20.77M | — | — | — |
| 2017 | $174000.00 | $-31.57M | -72.41% | -18,179.89% | -18,142.53% |
| 2018 | $129000.00 | $-32.20M | -21,718.60% | -25,985.27% | -24,963.57% |
| 2019 | $22.90M | $-24.61M | -77.17% | 113.30% | -107.44% |
| 2020 | $8.77M | $-27.40M | 100.00% | -344.69% | -312.40% |
| 2021 | $31.27M | $3.22M | 34.83% | 9.48% | 10.30% |
| 2022 | $3.88M | $-14.92M | -226.60% | -418.34% | -384.32% |
| 2023 | $1.55M | $-27.24M | -1,414.86% | -1,885.78% | -1,752.77% |
| 2024 | $11.54M | $-10.58M | 97.98% | -104.13% | -91.70% |
| 2025 | $19.39M | $-6.13M | 99.44% | -39.16% | -31.60% |